Integrated Growth Platform Calcium+Company offers end to end health communications through diversified divisions Calcium, Vitamin MD, PRotein, Amino, and Cobalt, plus an integrated strategy group grounded in behavioral science and data analytics. This structure enables a single partner capable of brand, medical, public relations, oncology marketing, and market access services across the product lifecycle. This setup presents a compelling opportunity for pharma and biotech brands seeking cohesive multi discipline campaigns.

Oncology and Access The firm places strong emphasis on oncology marketing (Amino) and market access (Cobalt), reinforced by a recent MD hire in oncology and a dedicated NYC PR office to support growth. This signals readiness to handle product launches and payer communications across jurisdictions. Target opportunities include oncology portfolios and therapies needing integrated marketing, evidence generation, and payer strategy.

Expansion Presence New York City expansion in 2025 expands regional footprint and capabilities for PRotein and client service. Proximity to US pharma brands can shorten cycles, improve collaboration, and enable onsite support and co located teams. Use this to approach brands seeking local responsiveness and scale.

Credible Partnerships Recognitions as a Best Places to Work and Independent Agency of the Year highlight mature talent, stability, and creative excellence. Clients often seek dependable partners with strong culture and low turnover, which can reduce risk in large campaigns and regulated communications.

Leadership Momentum Leadership momentum from CEO Judy Capano and Group President Greg Lewis, plus recent strategic hires in oncology marketing, marketing and innovation, and creative leadership, signals the ability to scale. This is supported by a tech forward approach, with behavioral insights and data analytics, HIPAA compliant processes, and tools like Clarivate and iCIMS to deliver compliant, evidence based campaigns.